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(piperazinyl) pyrido[3,2-f] quinazolin-4(1H)-yl]-1,3,4 thiadiazole 
derivatives have been designed and synthesised by incorporating  
four known  moieties  such  as  2-methylquinolin-5-ol, acetophenone, 
urea and 3-substitutedphenyl-4-amino-5-mercapto triazoles by 
using multi-step conventional reaction strategy. The synthesized 
derivatives were characterized by IR, 1H-NMR, Mass and 
elemental analysis (C, H, N). Furthermore the synthesized            
2-[(substitutedphenyl)-5-(1-phenyl-3-(piperazinyl)pyrido[3,2-f] 
quinazolin-4(1H)-yl]-1,3,4-thiadiazoles 4a-g were screened for 
antibacterial and antifungal activities. The bacterial panel 
consisted of Staphylococcus aureus, Escherichia coli, Klebsiella 
pneumoniae, Proteus vulgaris while fungal panel included of 
Aspergillus fumigatus (plant isolate), Candida glabrata, Candida 
albicans, Candida krusei. Ampicillin trihydrate and fluconazole 
were used as reference drugs for antibacterial and antifungal 
activity, respectively. Bacterial and fungal inhibition determined 
by disk diffusion and serial plates dilution method, respectively. 
Pathogenic inhibitions were determined by measuring the 
diameter of the inhibition zone in mm. Compound 4c 
demonstrated significant antibacterial and antifungal spectrum 
against all the tested microbes. 
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INTRODUCTION 
The heterocyclic derivatives have a great 
niche in the field of medicinal chemistry. 
Among the heterocyclic nuclei,  1,3,4-thiadiazole 
(Bekhit, et al., 2008; Palaska, et al., 2002; 
Labanauskas et al.,  2001; Onkol, et al., 2004; 
Schenone et al.,  2001) and quinoline (Gokce, et 
al.,  2001; Baldwin, et al.,  1980) are found 
versatile biological moieties. Current global 
issue is the increasing number of multi-drug 
resistance and the solution is found continual 
drug development program. 1,3,4-thiadiazole, 
1,2,4-triazole and quinoline (Gokce et al.,  2001; 
Baldwin, et al.,  1980) rings bearing derivatives 
have been extensively biologically studied for a 
number of pathological conditions including 
inflammation (Palaska,  et al.,  2002; Labanauskas, 
et al.,  2001; El-Sayed, et al.,  2004) pain (Onkol, 
et al., 2004; Gokce et al.,  2001;), hypertension 
(Baldwin, et al., 1980), antibacterial (Varvaresou, 
etal., 1998, 2000), antimyco-bacterial (Foroumadi, 
et al., 2001; Mamolo, et al., 2001), antimicrobial 
(Abdelhamid et al., 2016; Rezki, et al., 2015; 
Kallur, et al., 2012), antimycotic (Wujec, et al., 
2004; Zamani, et al., 2004), antifungal (Chen, et 
al., 2000; Zou, et al., 2002), anxiolytic (Clerici et 
al., 2001), antiproliferative (Rezki, et al., 2015) 
and antidepressant (Clerici et al., 2001) activities. 
In the present work, we have focused                      
on quinolin-5-ol and 2-amino-5-phenyl-1,3,4-
thiadiazole  due to their significant pharmaco-
logical profiles with the hope that the targeted 
derivative will show higher biological efficacy. 
 
MATERIALS AND METHODS 
All the chemicals used for the preparation 
of desired derivatives, were obtained from 
Sisco Research Laboratories (SRL), Mumbai, 
India; Qualigen Fine Chemicals,  Mumbai, India; 
E. Merck Ltd., New  Delhi, India. Reference 
drugs ampicillin trihydrate and fluconazole 
were procured from Ind-Swift Pharmaceutical, 
Panjab, India and Macleods Pharmaceutical, 
Mumbai, India respectively. The melting points 
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of the compounds were determined in open 
glass capillaries with the help of thermonic 
melting points apparatus (Campbell Electronics, 
Mumbai, India) and are uncorrected. The 
homogeneity of all the newly synthesized 
compounds were routinely checked by TLC on 
silica gel G plates and spots were located by 
using iodine chamber. Elemental analysis was 
performed in Heraeus C H N rapid analyser. 
The results were found within the ±0.4% of 
theoretical values. Infrared  spectra were recorded 
on KBr pellets on a Perkin Elmer system 2000 
FTIR spectrometer and 1H- NMR spectra on 
Bruker DPX 200 using TMS as internal 
standard. 
 
Antimicrobial screening  
All the newly synthesized compounds 
were screened for their antibacterial and 
antifungal activity. All the bacterial and fungal 
strains were clinical isolates, identified with 
conventional morphological and biochemical 
methods. Bacterial inhibition diameter was 
measured in mm. Microorganisms employed 
antibacterial studies were Staphylococcus aureus, 
Escherichia coli, Klebsiella pneumoniae and Proteus 
vulgaris. Disk diffusion method (Cruickshank,            
et al., 1975; Collins, 1976) was used  for 
determination of the preliminary antibacterial 
activity. Sterile 5mm Whatman no. 1 filter 
paper discs were used in the disc diffusion 
method. Batches of 100 disks were dispensed 
to each screw-capped bottle and sterilized by 
dry heat at 140°C for 1h. The test compounds 
were prepared with different concentrations 
using DMF. One hundred millilitres of the 
microbial suspension was spread onto nutrient 
agar plates. Disks of each concentration were 
for placed (in triplicate) in nutrient agar 
medium seeded with fresh bacteria separately. 
The incubation was carried out at 37°C for 24h. 
Ampicillin trihydrate was used as a standard 
drug. Solvent and growth controls were kept 
and zones of inhibition were noted (Table I). 
On the other hand, the newly prepared 
compounds were screened for their in vitro 
antifungal activity against Aspergillus fumigatus 
(plant isolate), Candida glabrata, Candida 
albicans and Candida krusei in DMSO by the 
serial plate dilution method (Khan, 1997; 
Varma, 1998). Fluconazole (antifungal) was used 
as reference drug. Sabouraud’s agar media were 
prepared by dissolving peptone (1g), D-glucose 
(4g), and agar (2g) in distilled water (100mL) 
and adjusting the pH to 5.7. Normal saline was 
used to make a suspension of the spore of 
fungal strain for lawning. A loopful of particular 
fungal strain was transferred to 3mL saline to 
get a suspension of the corresponding species. 
Agar media (20mL) was poured into each petri 
dish. Excess suspension was decanted and the 
plates were dried by placing in an incubator at 
37°C for 1h. Using an agar punch wells were 
made into each well labelled. A control was also 
prepared in triplicate and maintained at 37°C 
for 3-4 days. Antifungal activity was determined 
by measuring the diameter of the inhibition 





A mixture of 2-methylquinolin-5-ol 
(0.01mol), urea (0.01mol) and acetophenone 
(0.01mol) in ethanol was refluxed for 1h. The 
reaction mixture was cooled, poured into ice-
water slowly with continuous stirring, filtered 
and recrystallized by methanol: Yield: 70%; 
m.p.: 215°C; Rf: 0.64 (cycohexane: ethyl acetate).  
IR (KBr, cm−1): 3410 (NH), 1745 (C=O), 1625 
(C…C of aromatic ring), 1590 (C=N), 1290(C-
O-C). 1H-NMR (CDCl3, δ/ppm): 8.60-7.42(m, 
9H, Ar-H), 6.78 (bs, 1H, NH), 4.70 (s, 1H,   
CH-NH), 2.26 (s, 3H, Ph-CH3). Anal. calcd.             
for C18H14N2O2: C, 74.47; H, 4.86; N, 9.65; 
found C, 74.30; H,4.68; N,9.60. MS (m/z, %): 
290.10. 
 
Preparation of 3-chloro-8-methyl-1-phenyl 
-1H-[1,3]oxazino[5,6-f]quinoline (2) 
Phosphorous oxychloride (0.01mol) 
added slowly to a solution of compound 1 
(0.01mol) in toluene at R.T., stirred for              
30min, after reaction mixture refluxed for         
2h. Excess of solvent was distilled off. The 
reaction mixture cooled. The cooled mass 
poured into ice-water slowly with continuous 
stirring, neutralized with aqueous 3% KOH 
solution, filtered and recrystallized by ethanol: 
Yield: 69%; m.p.: 188°C; Rf: 0.70 (cycohexane: 
ethyl acetate).  IR (KBr, cm−1): 3400 (NH), 
1622 (C…C of aromatic ring), 1594 (C=N), 
1288 (C-O-C). 1H-NMR (CDCl3, δ/ppm):      
8.52-7.55 (m, 9H, Ar-H), 4.75 (s, 1H, CH-N-C), 
2.20 (s, 3H, Ph-CH3). Anal. calcd. for 
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C18H13N2O2Cl: C, 70.02; H,4.24; N, 9.07;   





A mixture of compound 2 (0.01mol), 
piperazine (0.015mol) and anhydrous sodium 
carbonate (1.25g) in absolute isopropanol was 
refluxed for 10h. The excess of amine and 
isopropanol was removed under reduced 
pressure and the residue was treated with 5% 
sodium bicarbonate solution to remove acidic 
impurities, filtered, washed with water properly 
and dried. It was crystallized from ethanol 
(95%) to give compound 3. Yield: 66%; mp 
179°C; Rf: 0.66 (cycohexane: ethyl acetate). IR 
(KBr, cm−1): 1620 (C…C of aromatic ring), 
1586 (C=N), 1370 (N-N), 1312 (C-N), 1277 (C-
O-C), 690 (C-S-C). 1H-NMR (CDCl3, δ/ppm): 
8.20-7.34 (m, 9H, Ar-H), 4.50 (s, 1H, CH-N-C), 
3.08 (s, 4H, 2XCH2), 2.53 (s, 3H, Ph-CH3), 2.28 
Table I. Antimicrobial screening of 2-[(substitutedphenyl)-5-(1-phenyl-3-(piperazinyl) 
pyrido[3,2 f] quinazolin-4(1H)-yl]-1,3,4-thiadiazoles (4a-g) 
 
Compound Substituent R 
Antifungal activity (mm) 
A. fumigatus A. flavus C. albicans C. glabrata 
1.      
2.      
3.  6 6 - - 
4a. H 8 6 - - 
4b. 2-Cl 10 10 6 8 
4c. 4-Cl 15 12 12 10 
4d. 4-NO2 8 6 - - 
4e. 2-OH 10 10 - 8 
4f. 3-OH 8 6 - 6 
4g. 4-OH 10 8 - 6 
Ampicilline  trihydrate - - - - 
Fluconazole 20 20 15 15 
DMF (control) - - - - 
 
- means no activity.  
 
Table II. Antimicrobial screening of 2-[(substitutedphenyl)-5-(1-phenyl-3-(piperazinyl) 
pyrido[3,2 f] quinazolin-4(1H)-yl]-1,3,4-thiadiazoles (4a-g) 
 
Compound Substituent R 
Antibacterial activity (mm) 
S. aureus E. coli P. vulgaris K. pneumoniae 
1.      
2.      
3.  - - 6 - 
4a. H - - 6 - 
4b. 2-Cl 12 8 10 12 
4c. 4-Cl 15 12 15 18 
4d. 4-NO2 - 6 - - 
4e. 2-OH 8 - 10 10 
4f. 3-OH 6 - 8 8 
4g. 4-OH 8 - 8 6 
Ampicilline  trihydrate 16 16 20 20 
Fluconazole - -  - 
DMF (control) - -  - 
 
- means no activity.  
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(s, 4H, 2XCH2), 1.61 (s, 1H, NH). Anal. calcd. 
for C22H22N4O: C, 73.72; H, 6.19; N, 15.63; 
found C, 73.70; H, 6.12; N,15.79. MS (m/z, %): 
358.18. 
 




The ethanolic solution of compound 3 
(0.01mol) and 2-amino-5-substitutedphenyl-
1,3,4-thiadiazoles (0.01mol) heated to reflux for 
2-3h. Excess of solvent was distilled off under 
reduced pressure and the residue cooled, 
poured into ice cold water, stirred, filtered, 
dried and recrystallised with appropriate 








Compound 4a: Yield: 67%; m.p.: 
227°C; Rf: 0.72 (cycohexane: ethyl acetate). IR 
(KBr, cm−1): 1625 (C…C of aromatic ring), 
1590 (C=N), 1366 (N-N), 1302 (C-N), 1293 (C-
O-C), 678 (C-S-C). 1H-NMR (CDCl3, δ/ppm): 
8.55-7.20 (m, 14H, Ar-H), 4.56 (s, 1H, CH-N-
C), 3.10 (s, 4H, 2XCH2), 2.55 (s, 3H, Ph-CH3), 
2.10 (s, 4H, 2XCH2), 1.50 (s, 1H, NH). Anal. 
calcd. for C30H27N7S: C, 69.61; H, 5.26; N, 
18.94; found C, 69.68; H, 5.23; N,18.98. MS 
(m/z, %): 517.20. 
Compound 4b: Yield: 56%; m.p.: 
189°C; Rf: 0.66 (cycohexane: ethyl acetate). IR 
(KBr, cm−1): 1627 (C…C of aromatic ring), 
1594 (C=N), 1368 (N-N), 1300 (C-N), 1287 (C-
O-C), 681 (C-S-C). 1H-NMR (CDCl3, δ/ppm): 
8.26-7.05 (m, 13H, Ar-H), 4.77 (s, 1H, CH-N-
C), 3.00 (s, 4H, 2XCH2), 2.50 (s, 3H, Ph-CH3), 
2.05 (s, 4H, 2XCH2), 1.41 (s, 1H, NH). Anal. 
calcd. for C30H26N7SCl: C, 65.26; H, 4.75; N, 
17.76; found C, 65.38; H, 4.73; N,18.00. MS 
(m/z, %): 551.17. 
Compound 4c: Yield: 60%; m.p.: 
196°C; Rf: 0.68 (cycohexane: ethyl acetate). IR 
(KBr, cm−1): 1619 (C…C of aromatic ring), 
1590 (C=N), 1364 (N-N), 1310 (C-N), 1290 (C-
O-C), 675 (C-S-C). 1H-NMR (CDCl3, δ/ppm): 
8.20-7.12 (m, 13H, Ar-H), 4.80 (s, 1H, CH-N-
C), 3.15 (s, 4H, 2XCH2), 2.63 (s, 3H, Ph-CH3), 
2.12 (s, 4H, 2XCH2), 1.32 (s, 1H, NH). Anal. 
calcd. for C30H26N7SCl: C, 65.26; H, 4.75; N, 
17.76; found C, 65.23; H, 4.80; N,17.72. MS 
(m/z, %): 551.17. 
Compound 4d: Yield: 55%; m.p.: 
243°C; Rf: 0.73 (cycohexane: ethyl acetate). IR 
(KBr, cm−1): 1627 (C…C of aromatic ring), 
1582 (C=N), 1359 (N-N), 1302 (C-N), 1298 (C-
O-C), 680 (C-S-C). 1H-NMR (CDCl3, δ/ppm): 
8.25-7.17 (m, 13H, Ar-H), 4.72 (s, 1H, CH-N-
C), 3.49 (s, 4H, 2XCH2), 2.58 (s, 3H, Ph-CH3), 
2.14 (s, 4H, 2XCH2), 1.44 (s, 1H, NH). Anal. 
calcd. for C30H26N8SO2: C, 64.04; H, 4.66; N, 
19.92; found C, 64.15; H, 4.69; N,19.74. MS 
(m/z, %): 562.19. 
Compound 4e: Yield: 60%; m.p.: 
172°C; Rf: 0.70 (cycohexane: ethyl acetate). IR 
(KBr, cm−1): 1630 (C…C of aromatic ring), 
1585 (C=N), 1364 (N-N), 1310 (C-N), 1290 (C-
O-C), 671 (C-S-C). 1H-NMR (CDCl3, δ/ppm): 
12.20 (ss, 1H, OH), 8.28-7.26 (m, 13H, Ar-H), 
4.80 (s, 1H, CH-N-C), 3.14 (s, 4H, 2XCH2), 
2.62 (s, 3H, Ph-CH3), 2.25 (s, 4H, 2XCH2), 1.30 
(s, 1H, NH). Anal. calcd. for C30H27N7SO: C, 
67.52; H, 5.10; N, 18.37; found C, 67.56; H, 
5.20; N,18.27. MS (m/z, %): 533.20. 
Compound 4f:  Yield: 56%; m.p.: 
155°C; Rf: 0.68 (cycohexane: ethyl acetate). IR 
(KBr, cm−1): 1627 (C…C of aromatic ring), 
1579 (C=N), 1372 (N-N), 1302 (C-N), 1285 (C-
O-C), 678 (C-S-C). 1H-NMR (CDCl3, δ/ppm): 
12.30 (ss, 1H, OH), 8.22-7.20 (m, 13H, Ar-H), 
4.82 (s, 1H, CH-N-C), 3.22 (s, 4H, 2XCH2), 
2.57 (s, 3H, Ph-CH3), 2.12 (s, 4H, 2XCH2), 1.23 
(s, 1H, NH). Anal. calcd. for C30H27N7SO: C, 
67.52; H, 5.10; N, 18.37; found C, 67.54; H, 
5.12; N,18.30. MS (m/z, %): 533.20. 
Compound 4g: Yield: 62%; m.p.: 
182°C; Rf: 0.72 (cycohexane: ethyl acetate). IR 
(KBr, cm−1): 1630 (C…C of aromatic ring), 
1585 (C=N), 1364 (N-N), 1306 (C-N), 1276 (C-
O-C), 675 (C-S-C). 1H-NMR (CDCl3, δ/ppm): 
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12.22 (ss, 1H, OH), 8.17-7.18 (m, 13H, Ar-H), 
4.73 (s, 1H, CH-N-C), 3.17 (s, 4H, 2XCH2), 
2.68 (s, 3H, Ph-CH3), 2.25 (s, 4H, 2XCH2), 1.36 
(s, 1H, NH). Anal. calcd. for C30H27N7SO: C, 
67.52; H, 5.10; N, 18.37; found C, 67.60; H, 
5.24; N,18.29. MS (m/z, %): 533.20. 
 
RESULTS AND DISCUSSION 
Chemistry 
3-substitutedphenyl-4-amino-5-mercapto 
triazoles were prepared according to the 
reported method [20-23]. Ethanolic mixture of 
2-methylquinolin-5-ol, urea and acetophenone 
refluxed to give 8-methyl-1-phenyl-1H-
[1,3]oxazino[5,6-f]quinolin-3(2H)one (1) in 
good yield. Refluxing of compound 1 with 
phosphorous oxy chloride in DMF solvent 
furnished 3-chloro-8-methyl-1-phenyl-1H-
[1,3]oxazino[5,6-f]quinoline (2) which on 
further reacted with piperazine to yield 8-
methyl-1-phenyl-3-piperazinyl-1H-
[1,3]oxazino[5,6-f]quinoline (3). Reaction of 3-
substitutedphenyl-4-amino-5-mercapto 
triazoles with compound 3 resulted into 
targeted moieties 2-[(substitutedphenyl)-5-(1-
phenyl-3-(piperazinyl)pyrido[3,2-f] quinazolin-
4(1H)-yl]-1,3,4 thiadiazoles (4a-g) [Scheme-1]. 
  
Antimicrobial activity 
Out of all the tested  derivatives,  
compound  4c showed better antimicrobial 
activity.  Screening data cleared that compound 
1 and 2 were inactive against all the used 
pathogens. Compound  3 showed  poor microbial 
inhibition. Among the derivative 4a-g; derivative 
4a, 4d elicited poor inhibitions;  4e, 4f and      
4g showed almost similar milder potency            
while derivative 4b, 4c exhibited  moderate 
antimicrobial activity. Chloro substituted 
compounds 4b and 4c displayed significant 
broader microbial inhibition against pathogens.  
 
CONCLUSION  
Antimicrobial evaluation of all the 
synthesised compounds showed that 
conversion of compound 3 into substituted-
1,3,4-thiadiazoles 4a-g enhances antibacterial as 
well as antifungal activities. Compound 4c 
possessing 4-chlorophenyl substitution; 
displayed the most potent antimicrobial 
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